Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease

被引:27
|
作者
Sukhu, K [1 ]
Poovalingam, V
Mahomed, R
Giangrande, PLF
机构
[1] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[2] Churchill Hosp, Thrombosis Unit, Oxford OX3 7LJ, England
[3] King Edward VIII Hosp, Dept Haematol, Nelson R Mandela Sch Med, Durban, South Africa
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2003年 / 25卷 / 04期
关键词
von Willebrand factor : Ag; race; ethnic variation; normal range; von Willebrand disease;
D O I
10.1046/j.1365-2257.2003.00523.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The amount and function of von Willebrand factor (VWF), measured against a panel of laboratory tests, is the normal basis for the diagnosis of von Willebrand's disease (VWD). The normal range for each test is usually obtained by assaying samples from a cross section of the local population or from a manufacturer's kit insert. While collecting normal controls for another study, population from Durban in South Africa, with its distinct ethnic mix of Africans, Indians and Caucasians were also studied. Previously, Indians from their subcontinent have not been looked at separately and compared with Africans and Caucasians. It is confirmed in a previous study (Miller, Dilley, Richardson, Craig, Evatt. (2001) American Journal of Hematology 67, 125) that African Americans had significantly higher VWF:Ag and FVIII levels when compared with Caucasians. In addition, it was found that there was a significant difference in VWF:Ag levels between Indians and Africans, and between Caucasians and Africans, whereas no significant difference between Indians and Caucasians. Africans, Indians and Caucasians with blood group O showed significantly lower VWF:Ag and FVIII than the other ABO blood groups. Normal ranges of VWF for different blood groups are well established and this information should be utilized while considering a diagnosis of VWD. It is proposed here that the influence of racial origin should also be considered in the clinical and laboratory evaluation of VWD.
引用
收藏
页码:247 / 249
页数:3
相关论文
共 50 条
  • [21] Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
    Stufano, Francesca
    Baronciani, Luciano
    Bucciarelli, Paolo
    Boscarino, Marco
    Colpani, Paola
    Pagliari, Maria Teresa
    Peyvandi, Flora
    [J]. HAEMOPHILIA, 2020, 26 (02) : 298 - 305
  • [22] Laboratory assays for von Willebrand factor: Relative contribution to the diagnosis of von Willebrand's disease
    Favaloro, EJ
    Koutts, J
    [J]. PATHOLOGY, 1997, 29 (04) : 385 - 391
  • [23] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE
    MARAGALL, S
    CASTILLO, R
    ORDINAS, A
    LIENDO, F
    RODRIGUEZ, M
    [J]. THROMBOSIS RESEARCH, 1979, 14 (2-3) : 495 - 500
  • [24] Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
    Vangenechten, Inge
    Gadisseur, Alain
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (06) : 1024 - 1034
  • [25] Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset
    Schaefer, Beverly A.
    Cheng, Dunlei
    Kouides, Peter
    [J]. HAEMOPHILIA, 2022, 28 (01) : 109 - 116
  • [26] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [27] von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
    Sanders, Yvonne V.
    Groeneveld, Dafna
    Meijer, Karina
    Fijnvandraat, Karin
    Cnossen, Marjon H.
    van der Bom, Johanna G.
    Coppens, M.
    de Meris, Joke
    Laros-van Gorkom, Britta A. P.
    Mauser-Bunschoten, Eveline P.
    Leebeek, Frank W. G.
    Eikenboom, Jeroen
    [J]. BLOOD, 2015, 125 (19) : 3006 - 3013
  • [28] Diagnosis of von Willebrand disease
    Federici, AB
    [J]. HAEMOPHILIA, 1998, 4 (04) : 654 - 660
  • [29] Diagnosis of von Willebrand disease
    Ingerslev, J
    Gürsel, T
    [J]. HAEMOPHILIA, 1999, 5 : 50 - 56
  • [30] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79